These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8682090)

  • 1. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).
    Maisch B; Hufnagel G; Schönian U; Hengstenberg C
    Eur Heart J; 1995 Dec; 16 Suppl O():173-5. PubMed ID: 8682090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results.
    Hufnagel G; Pankuweit S; Richter A; Schönian U; Maisch B
    Herz; 2000 May; 25(3):279-85. PubMed ID: 10904853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy.
    Figulla HR; Stille-Siegener M; Mall G; Heim A; Kreuzer H
    J Am Coll Cardiol; 1995 Apr; 25(5):1170-5. PubMed ID: 7897131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease.
    Pankuweit S; Portig I; Eckhardt H; Crombach M; Hufnagel G; Maisch B
    Herz; 2000 May; 25(3):221-6. PubMed ID: 10904842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of dilated cardiomyopathies with and without inflammation].
    Hufnagel G; Pankuweit S; Maisch B
    Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy.
    Grumbach IM; Heim A; Pring-Akerblom P; Vonhof S; Hein WJ; Müller G; Figulla HR
    Acta Cardiol; 1999 Apr; 54(2):83-8. PubMed ID: 10378019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy.
    Mirić M; Misković A; Vasiljević JD; Keserović N; Pesić M
    Eur Heart J; 1995 Dec; 16 Suppl O():150-2. PubMed ID: 8682086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape from cardiomyocyte apoptosis by enterovirus persistence due to elevated soluble Fas-receptors.
    Alter P; Maisch B
    Z Kardiol; 2004 Jul; 93(7):524-32. PubMed ID: 15243763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.
    Caforio AL; Marcolongo R; Jahns R; Fu M; Felix SB; Iliceto S
    Heart Fail Rev; 2013 Nov; 18(6):715-32. PubMed ID: 23114995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy].
    Noutsias M; Pauschinger M; Kühl U; Schultheiss HP
    MMW Fortschr Med; 2002 Apr; 144(14):36-40. PubMed ID: 12014275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical picture and differential diagnosis of cardiomyopathy and myocarditis].
    Sigusch HH; Reinhardt D; Figulla HR
    Med Klin (Munich); 1998 Apr; 93(4):236-9. PubMed ID: 9594533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endomyocardial biopsy in myocarditis].
    Maisch B
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S15. PubMed ID: 10819001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].
    Pankuweit S; Hufnagel G; Eckhardt H; Herrmann H; Uttecht S; Maisch B
    Med Klin (Munich); 1998 Apr; 93(4):223-8. PubMed ID: 9594531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy.
    Sole MJ; Liu P
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):99A-105A. PubMed ID: 8376702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterovirus-induced myocarditis: hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-alpha.
    Heim A; Stille-Siegener M; Kandolf R; Kreuzer H; Figulla HR
    Clin Cardiol; 1994 Oct; 17(10):563-5. PubMed ID: 8001305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus infection and dilated cardiomyopathy.
    Richardson PJ; Why HJ; Archard LC
    Postgrad Med J; 1992; 68 Suppl 1():S17-20. PubMed ID: 1329059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy of myocarditis?].
    Schultheiss HP; Kühl U; Janda I; Schanwell M; Strauer BE
    Herz; 1992 Apr; 17(2):112-21. PubMed ID: 1577363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enteroviral myocarditis and dilated cardiomyopathy].
    Kandolf R
    Med Klin (Munich); 1998 Apr; 93(4):215-22. PubMed ID: 9594530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
    Castellano G; Affuso F; Di Conza P; Fazio S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.